Hier finden Fachkreise und Patienten Kurzzusammenfassungen (“Abstracts”) wissenschaftlicher Publikationen zu den in unseren Produkten enthaltenen Wirkstoffen. Falls vorhanden, ist ein Link zur Online-Version der Publikation angegeben.
Karakulak UN et al. 2015; An arrhythmic episode after mercury exposure and successful treatment with chelation therapy: A case report; Anatol. J. Cardiol. 15:586-91
Study design: This report surveys the case of a female patient presenting weakness of the limbs, malaise, fatigue, atypical chest pain and palpitation due to mercury … » Mehr
Gaidukov SN et al. 2013; Features of the early neonatal period at children born from mothers with the critical values of mercury in their blood; Mod. Problems Sci. Educat. No. 6
Study design: This study compared several neonatal parameters of babies born by mothers with critical level of mercury in their blood who were either treated (group 1) with … » Mehr
Mirzoev EB et al. 2015; The influence of hexacyanoferrate (II) potassium-ferric(III) as a radionuclide sorbent fed at different doses on clinical, hematological and physiological parameters in rats; Agric. Biol. 50(2):237-44
Study Design: Wistar rats received 0 mg/kg, 11.6 mg/kg, 23.2 mg/kg or 32.4 mg/kg hexacyanoferrate (II) potassium-ferric (III) orally for 30 days to compare influence on … » Mehr
Parajuli D et al. 2013; Prussian blue nanoparticles for the enrichment of radioactive cesium in colutions; Waste Management Conference: International collaboration and continuous improvement, Phoenix, AZ (USA), 24-28 Feb 2013
Study Design: Prussian Blue (PB) nanoparticles in various forms were compared for their ability to adsorb cesium (Cs) from water. Results: Water dispersible nano-PB could … » Mehr